Skip to Main Content

Paper Details

Progressive immune dysfunction with advancing disease stage in renal cell carcinoma.
Cancer Cell
214
2021
CD8+, CD8+ T cells, M2, M2-like macrophages, T cell receptor, cancer, ccRCC, clear cell renal cell carcinoma, immune cells, immune dysfunction, myeloid compartment, patients, pro-inflammatory macrophages, renal cell carcinoma, single-cell RNA, tumor
Author NameAffiliation
Ang CuiBroad Institute of MIT and Harvard
Rafael A IrizarryDana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health
Rafael A IrizarryDana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health
Toni K ChoueiriDana-Farber Cancer Institute, USA Harvard Medical School
Catherine J WuDana-Farber Cancer Institute, USA Harvard Medical School, USA Broad Institute of MIT and Harvard
  • 1 - 5

Datasets

Release 1.2